| I. Process of care |
% |
|
A. Timely detection of type 2 diabetes complications and comorbidity in the last year (n = 142)
|
|
| At least one measurement of hemoglobin A1C |
99.3 |
| Comprehensive foot evaluation |
98.6 |
| Measurement of creatinine and rate of glomerular filtration |
90.1 |
| Four or more clinical encounters during year |
95.1 |
|
B. Non-pharmacological treatment in the last year (n = 142)
|
|
| Diabetes self-care education provided in home visit |
50 |
|
C. Pharmacological treatment in the last year
|
|
| Overweight/obese (BMI ≥25 kg/m2) patients with hemoglobin A1C ≥ 6.5 who received metformin, unless contraindicated (n = 66) |
98.8 |
| Patients with hemoglobin A1C ≥ 8% who received insulin (n = 64) |
37.5 |
| Patients with hypertension receiving inhibitors of angiotensin converting enzyme or angiotensin-receptor blocker, unless contraindicated (n = 65) |
95.4 |
| II. Health outcomes |
|
| Hemoglobin A1C < 8% in last measurement (n = 142) |
54.9 |
| Blood pressure <140/90 mmHg in last 3 measurements (n = 139) |
59.0 |
| Hemoglobin A1C < 8% in last measurement and blood pressure <140/90 mmHg in last 3 measurements (n = 139) |
29.5 |
